Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration
Jiafa Ren, Yuemei Xu, Xiaohan Lu, Liming Wang, Shintaro Ide, Gentzon Hall, Tomokazu Souma, Jamie R. Privratsky, Robert F. Spurney, Steven D. Crowley
Jiafa Ren, Yuemei Xu, Xiaohan Lu, Liming Wang, Shintaro Ide, Gentzon Hall, Tomokazu Souma, Jamie R. Privratsky, Robert F. Spurney, Steven D. Crowley
View: Text | PDF
Research Article Nephrology

Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration

  • Text
  • PDF
Abstract

The transcription factor Twist1 regulates several processes that could impact kidney disease progression, including epithelial cell differentiation and inflammatory cytokine induction. Podocytes are specialized epithelia that exhibit features of immune cells and could therefore mediate unique effects of Twist1 on glomerular disease. To study Twist1 functions in podocytes during proteinuric kidney disease, we employed a conditional mutant mouse in which Twist1 was selectively ablated in podocytes (Twist1-PKO). Deletion of Twist1 in podocytes augmented proteinuria, podocyte injury, and foot process effacement in glomerular injury models. Twist1 in podocytes constrained renal accumulation of monocytes/macrophages and glomerular expression of CCL2 and the macrophage cytokine TNF-α after injury. Deletion of TNF-α selectively from podocytes had no impact on the progression of proteinuric nephropathy. By contrast, the inhibition of CCL2 abrogated the exaggeration in proteinuria and podocyte injury accruing from podocyte Twist1 deletion. Collectively, Twist1 in podocytes mitigated urine albumin excretion and podocyte injury in proteinuric kidney diseases by limiting CCL2 induction that drove monocyte/macrophage infiltration into injured glomeruli. Myeloid cells, rather than podocytes, further promoted podocyte injury and glomerular disease by secreting TNF-α. These data highlight the capacity of Twist1 in the podocyte to mitigate glomerular injury by curtailing the local myeloid immune response.

Authors

Jiafa Ren, Yuemei Xu, Xiaohan Lu, Liming Wang, Shintaro Ide, Gentzon Hall, Tomokazu Souma, Jamie R. Privratsky, Robert F. Spurney, Steven D. Crowley

×

Figure 3

Twist1 in podocytes limits albuminuria and podocyte injury induced by NTS in mice.

Options: View larger image (or click on image) Download as PowerPoint
Twist1 in podocytes limits albuminuria and podocyte injury induced by NT...
(A) Urinary albumin concentration in WT and Twist1-PKO mice on day 9 vehicle or NTS (n = 4–9, Kruskal-Wallis test). (B) Representative SDS-PAGE showing the urine proteins in cohorts of mice. (C) Representative images of kidney sections from WT and Twist1-PKO mice on day 9 vehicle or NTS. Red arrowheads indicate glomerulosclerosis; red arrows indicate tubular casts. Scale bar: 40 μm. (D) Kidney glomerulosclerosis scores in groups (n = 4–9, Kruskal-Wallis test). (E) Renal mRNA expression of podocin, nephrin, and podocalyxin in WT and Twist1-PKO mice after NTS injection (7–9, t test). (F) Representative Western blots for nephrin and podocin proteins in glomeruli isolated from WT and Twist1-PKO mice on day 4 NTS. (G) Semiquantitative determination of nephrin and podocin protein levels from blots in F (n = 7–9, t test). (H) Representative immunostaining for WT1 protein in the groups and electron microscopy showing the glomerular filtration barrier in the groups. (I) Quantitative determination of WT1-positive cells in glomeruli in different groups (n = 3–6, Student-Newman-Keuls test). Data represent mean ± SEM. All t tests were 2 tailed. *P < 0.05, #P < 0.05. Red arrowheads indicate foot processes. Scale bar: 40 μm (upper), 1 μm (lower). veh, vehicle; NTS, nephrotoxic serum; EM, electron microscopy; Twist1-PKO, Pod-Cre Twist1fl/fl.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts